What is IPF ACE-IPF trial (warfarin)?

Category: Others


The IPF-ACE trial investigated whether treatment with warfarin improves clinical outcome in subjects with IPF. It was found to not be effective for IPF patients.NCT00957242

Side effects

Side effects as an overall problem

Side effects as an overall problem
Severity Evaluations
Severe 0
Moderate 0
Mild 0
None 1

Commonly reported side effects and conditions associated with IPF ACE-IPF trial (warfarin)

Side effect Patients


Based on patients currently using IPF ACE-IPF trial (warfarin)

Dosage Patients
6 mg daily 1


Currently using IPF ACE-IPF trial (warfarin)

Duration Patients
2 - 5 years 1
Adherence Evaluations
Always 1
Usually 0
Sometimes 0
Never taken as prescribed 0
Burden Evaluations
Very hard to take 0
Somewhat hard to take 0
A little hard to take 0
Not at all hard to take 1
Last updated:
There are no evaluations for IPF ACE-IPF trial (warfarin).